REYON Pharmaceutical Co., Ltd. (102460.KS)

KRW 13020.0

(-2.18%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 499.77 Billion 484.69 Billion 477.97 Billion 317.6 Billion 274.48 Billion 303.16 Billion
Total Current Assets 99.81 Billion 109 Billion 164.8 Billion 117.77 Billion 131.58 Billion 224.42 Billion
Cash And Short Term Investments 24.24 Billion 36.06 Billion 97.44 Billion 45.46 Billion 59.32 Billion 151.18 Billion
Cash and Cash Equivalents 24.1 Billion 16.04 Billion 66.74 Billion 12.19 Billion 5.82 Billion 8.77 Billion
Short Term Investments 134.02 Million 20.01 Billion 30.7 Billion 33.27 Billion 53.5 Billion 142.4 Billion
Net Receivables 39.97 Billion 42.82 Billion 40.92 Billion 43.86 Billion 48.25 Billion 52.44 Billion
Inventory 35.17 Billion 30.1 Billion 26.43 Billion 28.43 Billion 24 Billion 20.79 Billion
Other Current Assets 418.17 Million 660.00 -270.00 -350.00 -60.00 -430.00
Total Non-Current Assets 399.96 Billion 375.68 Billion 313.17 Billion 199.83 Billion 142.89 Billion 78.74 Billion
Net PPE 368.34 Billion 340.56 Billion 281.15 Billion 170.97 Billion 114.3 Billion 56.15 Billion
Good Will And Intangible Assets 4.19 Billion 4.2 Billion 4.22 Billion 4.24 Billion 4.69 Billion 4.53 Billion
Good Will - - - - - -
Intangible Assets 4.19 Billion 4.2 Billion 4.22 Billion 4.24 Billion 4.69 Billion 4.53 Billion
Long-Term Investments 21.3 Billion 6.19 Billion -6.15 Billion -12.12 Billion -32.68 Billion -127.11 Billion
Tax Assets 5.07 Billion 4.1 Billion 2 Billion 2.05 Billion 1.63 Billion 1.24 Billion
Other Non Current Assets 1.04 Billion 20.61 Billion 31.93 Billion 34.68 Billion 54.95 Billion 143.92 Billion
Other Assets - - -10.00 - - -
Total Liabilities 251.15 Billion 236.92 Billion 232.74 Billion 87.52 Billion 52.19 Billion 77.77 Billion
Total Current Liabilities 125.6 Billion 47.95 Billion 47.5 Billion 48.75 Billion 33.03 Billion 42.5 Billion
Account Payables 8.18 Billion 4.79 Billion 4.73 Billion 4.16 Billion 4.11 Billion 3.68 Billion
Tax Payables 852.4 Million 733.47 Million 426.47 Million 297.61 Million 437.67 Million 25.27 Billion
Short Term Debt 102.26 Billion 24.75 Billion 24.41 Billion 22.99 Billion 14.49 Billion -2.5 Billion
Deferred Revenue 1.43 Billion 1.79 Billion 17.01 Billion 20.26 Billion 12.88 Billion 2.5 Billion
Other Current Liabilities 13.71 Billion 16.6 Billion 1.34 Billion 1.33 Billion 1.53 Billion 38.81 Billion
Total Non Current Liabilities 125.54 Billion 188.97 Billion 185.23 Billion 38.76 Billion 19.15 Billion 35.26 Billion
Long-Term Debt 121 Billion 185.44 Billion 182.9 Billion 36.44 Billion 19.15 Billion 35.26 Billion
Deferred Revenue Non Current 1.78 Billion - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.74 Billion 3.52 Billion 2.32 Billion 2.32 Billion -340.00 -
Other Liabilities - 10.00 -10.00 - -10.00 -
Total Equity 248.62 Billion 247.76 Billion 245.23 Billion 230.08 Billion 222.29 Billion 225.39 Billion
Stock Holders Equity 248.62 Billion 247.76 Billion 245.23 Billion 230.08 Billion 220.2 Billion 223.52 Billion
Common Stock 9.29 Billion 8.99 Billion 8.99 Billion 8.78 Billion 8.38 Billion 8.38 Billion
Retained Earnings 198.27 Billion 205.15 Billion 202.28 Billion 200.2 Billion 200.13 Billion 203.28 Billion
Accumulated other comprehensive income 8.92 Billion 7.33 Billion 7.53 Billion 8.79 Billion 9.03 Billion 10.02 Billion
Common Stock Equity 248.62 Billion 247.76 Billion 245.23 Billion 230.08 Billion 220.2 Billion 223.52 Billion
Capital Lease Obligation 1.78 Billion 3.48 Billion 2.38 Billion 5.21 Billion 7.05 Billion -
Total Investments 21.44 Billion 26.21 Billion 24.55 Billion 21.14 Billion 20.81 Billion 15.28 Billion
Total Debt 225.05 Billion 210.2 Billion 207.31 Billion 59.43 Billion 33.65 Billion 35.26 Billion
Net Debt 200.94 Billion 194.15 Billion 140.57 Billion 47.23 Billion 27.83 Billion 26.48 Billion

Balance Sheet Charts